PATENT CLAIM ANALYSIS

Application Number: 16058945
Application Type: Utility
Filing Date: 2018-08
Publication Date: 2019-07
Patent Classification: ["514", "222500"]

Abstract:
Compounds active on protein kinases are described, as well as methods of using such compounds to treat diseases and conditions associated with aberrant activity of protein kinases.

Claim (Index 4):
The method according to  claim 1 , wherein the Raf mediated disease or condition is a neoplastic disease selected from the group consisting of melanoma, glioma, sarcoma, colorectal cancer, lung cancer, breast cancer, pancreatic cancer, thyroid cancer, renal cancer, ovarian cancer, histiocytic lymphoma, neurofibromatosis, acute myeloid leukemia, myelodysplastic syndrome, leukemia, tumor angiogenesis, medullary thyroid cancer, carcinoid, small cell lung cancer and pheochromocytoma.

Metadata:
- Claim Count in Document: 18.0
- Percentile: 96.0
- Lexical Diversity: 1.16
- Patent Class: 514.0
- Transitional Phrase Type: closed
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['11473347', '14514232', '12773798', '12949741', '11960590']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8030823598481803
- 35 USC 102 Novelty (BERT): 0.5506672177527192
- Combined Prediction Score: 0.7778408456386342
- Mean Citation Score: 382.887468
- Max Citation Score: 408.66998
- Similarity Product: 325.6124627656484

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test